Please login to the form below

Not currently logged in
Email:
Password:

Sanofi and Audion in hearing partnership

Sanofi has entered into a two-year research collaboration with the Audion Therapeutics to develop potential treatments for hearing loss

Sanofi has entered into a two-year research collaboration with the Audion Therapeutics to develop potential treatments for hearing loss through the optimisation of small molecules by using a regenerative medicine approach.

The research will use technology developed at the Massachusetts Eye and Ear Infirmary in the Eaton-Peabody Laboratory, a basic research facility dedicated to the study of hearing and deafness, by investigator and Audion co-founder Dr Albert Edge, who has strong expertise in stem cells and inner ear biology. Audion licensed Dr Edge's technology from Mass Eye and Ear. 

Under the terms of the agreement, Sanofi has an option to license technology rights from Audion related to research conducted under the collaboration.

<

Dr Elias Zerhouni, president of global R&D at Sanofi, said: "Our new relationship with Audion demonstrates our commitment to work with partners on conditions with unmet and growing medical needs, such as hearing loss.

"This collaboration is a multi-disciplinary approach with our internal Aging Therapeutic Strategic Unit and our Early-to-Candidate Unit working together to advance novel therapies in the field of otolaryngology using the most advanced technologies available to study cochlear biology," he added.

16th June 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics